Thomas Vo compensation by year
Nutex Health Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $151,310 | $251,310 | $931,841 | $992,077 | $557,692 | $1,000,000 |
| Bonus | $0 | $0 | $0 | $0 | $500,000 | $504,880 |
| Stock awards | $0 | $0 | $0 | $0 | $81,000 | $669,950 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $7,536 | $6,354 | $6,384 | $13,634 | $23,522 | $22,590 |
| Total | $158,846 | $257,664 | $938,225 | $1,005,711 | $1,162,214 | $2,197,420 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nutex Health Inc. DEF 14A filed March 13, 2026, accession 0001628280-26-017681, and prior-year filings.
How this page was built: the Nutex Health Inc. filed document, accession 0001628280-26-017681. Every figure is read from that document and cited to the page and table it appears in. Filed March 13, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 20,000 | $3,296,400 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Nutex Health Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
3 Form 4 lines since the FY2025 proxy (filed March 13, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-28 | Other | — | 75,747 | $0.00 | 2,103,014 |
| 2026-04-09 | Other | — | 184,071 | $0.00 | 2,027,267 |
| 2026-03-10 | Exercise or conversion derivative | — | 4,841 | $0.00 | 16,507 |
The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Nutex Health discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $3,000,000 | $3,296,400 | $22,590 | $6,318,990 |
Per the Potential Payments Upon Termination or Change in Control table in Nutex Health Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Nutex Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Thomas Vo · this page | Chief Executive Officer and Chairman of the Board | $2,197,420 |
| Warren Hosseinion | President | $1,705,421 |
| Joshua DeTillio | Former Chief Operating Officer | $952,132 |
| Jon Bates | Chief Financial Officer | $923,205 |
| Michael Chang | Chief Medical Officer | $716,585 |
| Wesley Bamburg | Chief Operating Officer | $105,972 |
Board service
Nutex Health board · FY2022–FY2025How this board is paid
Company policy: Nutex Health pays directors a $150,000 cash retainer and $70,000 in RSUs. As stated in Nutex Health's FY2025 proxy.
The full Nutex Health compensation record
free company briefThis page is one person within Nutex Health's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Nutex Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Nutex Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.